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Abstract
Background: Animals respond to inflammation by suppressing normal high-energy activities, including feeding and
locomotion, in favor of diverting resources to the immune response. The cytokine interleukin-1 beta (IL-1β) inhibits
normal feeding and locomotor activity (LMA) via its actions in the central nervous system (CNS). Behavioral changes
in response to IL-1β are mediated by myeloid differentiation factor 88 (MyD88) in non-hematopoietic cells. It is
unknown whether IL-1β acts directly on neurons or requires transduction by non-neuronal cells.
Methods: The Nestin-cre mouse was crossed with MyD88lox mice to delete MyD88 from neurons and glia in the
CNS (MyD88ΔCNS). These mice were compared to total body MyD88KO and wild type (WT) mice. Mice had cannulae
stereotactically placed in the lateral ventricle and telemetry transponders implanted into the peritoneum. Mice were
treated with either intracerebroventricular (i.c.v.) IL-1β (10 ng) or vehicle. Food intake, body weight and LMA were
continuously monitored for 24 h after treatment. I.c.v. tumor necrosis factor (TNF), a MyD88-independent cytokine,
was used to control for normal immune development. Peripheral inflammation was modeled using intraperitoneal
lipopolysaccharide (LPS). Groups were compared using two-way ANOVA with Bonferroni post-test. Efficacy of
recombination was evaluated using tdTomato reporter mice crossed with the Nestin-cre mouse. MyD88 deletion
was confirmed by Western blot.
Results: I.c.v. IL-1β treatment caused a significant reduction in feeding, body weight and LMA in WT mice.
MyD88KO mice were protected from these changes in response to i.c.v. IL-1β despite having intact behavioral
responses to TNF. Cre-mediated recombination was observed in neurons and astrocytes, but not microglia or
endothelial cells. In contrast to MyD88KO mice, the behavioral responses of MyD88ΔCNS mice to i.c.v. IL-1β or
intraperitoneal (i.p.) LPS were indistinguishable from those of WT mice.
Conclusion: Sickness behavior is mediated by MyD88 and is dependent on the activity of cytokines within the
brain. Our results demonstrate that MyD88 is not required in neurons or astrocytes to induce this behavioral
response to IL-1β or LPS. This suggests that a non-Nestin expressing cell population responds to IL-1β in the CNS
and transduces the signal to neurons controlling feeding and activity.
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Background
Systemic inflammation elicits an evolutionarily conserved
behavioral response, including anorexia, lethargy, anhedo-
nia and hyperalgesia [1]. Collectively known as sickness
behavior, this response is likely adaptive in the acute set-
ting in that it reduces energy expenditure associated with
foraging, but becomes pathological when present in a
chronic state. Individuals suffering from chronic inflam-
matory illnesses, such as cancer, chronic renal failure, con-
gestive heart failure and many others, exhibit decreased
appetite and decreased energy to complete activities in the
course of daily living [2]. Decreased nutritional intake con-
sequent to decreased appetite contributes to ongoing
weight loss in such individuals. Both weight loss and
decreased activity not only negatively impact quality of life,
but also are tightly correlated with mortality [3,4]. Despite
this, there are currently no effective therapeutic interven-
tions that alter the impact of the behavioral response to
disease.
Sickness behavior is associated with increases in in-
flammatory cytokines, both circulating and in the central
nervous system (CNS) [5]. Administration of inflamma-
tory cytokines recapitulates the behavioral features of
sickness, whereas cytokine antagonism has some efficacy
in reversing these behaviors [6,7]. However, the mechan-
ism by which inflammatory cytokines mediate behavioral
changes remains incompletely described. Myeloid differ-
entiation factor 88 (MyD88) is a signaling protein down-
stream from Toll-like receptors (TLRs) and the type I
interleukin 1 receptor (IL-1RI). Sickness behavior in re-
sponse to the inflammatory cytokine interleukin-1β (IL-
1β) or the bacterial cell wall product LPS requires intact
MyD88 signaling [8]. A series of bone marrow transplant
experiments between WT and MyD88KO mice localized
this requirement for MyD88 to a non-transplantable
(that is, non-hematopoeitic) cell population [9]. Direct
administration of IL-1β into the brain potently sup-
presses feeding and locomotor activity (LMA) indicating
that cytokines act within the CNS to derive their behav-
ioral effect [10]. Cytokine receptors are expressed on
neurons known to regulate feeding and other behavioral
responses, and neuron-specific disruption of these sig-
naling pathways alters the behavioral responses to cyto-
kine administration [11-13]. However, others provide
evidence that cerebrovascular endothelial cells and peri-
vascular macrophages are the targets of inflammatory
cytokines in mediating sickness behavior [14-16].
To explore these distinct mechanisms of cytokine action
and to establish the necessity of CNS MyD88 expression,
we performed intracerebroventricular (i.c.v.) injections of
IL-1β in MyD88 knockout mice (MyD88KO) and mice
with a targeted deletion of MyD88 in the CNS only
(MyD88ΔCNS). Our work here describes the feeding and
locomotor responses to CNS inflammation, and the role of




Male C57BL/6 J wild type and MyD88KO (Stock#
009088) mice were purchased from The Jackson Labs
(Bar Harbor, ME, USA). Nestin-cre mice (Stock#
003771) and MyD88 Flox mice (Stock# 008888) were
obtained from The Jackson Labs, and crossed to
obtained Nes-cre+/−/MyD88 Flox+/+ mice. These mice
were then crossed back to the original MyD88 Flox+/+
line to obtain MyD88ΔCNS and MyD88Flox littermate
controls. Nestin-cre mice were also bred to mice harbor-
ing a Flox-Stop-Flox tdTomato behind a CAG promoter
knocked into the ROSA locus (The Jackson Labs, Stock#
007908) or nuclear-localized green fluorescent protein/
beta-galactosidase fusion protein (GNZ) (The Jackson
Labs, Stock# 008606) to examine the cellular specificity
of cre-mediated recombination. All mice were genotyped
using standard protocols from The Jackson Labs. All ani-
mals were maintained on a normal 12:12 hr light/dark
cycle and provided ad libitum access to water and food
(Purina rodent diet 5001; Purina Mills, St. Louis, MO,
USA). Mice were used for experiments at between 6 and
10 weeks of age. Experiments were conducted in accord-
ance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals, and approved by
the Animal Care and Use Committee of Oregon Health
and Science University.
Intracerebroventricular injection
26-gauge lateral ventricle cannulas were placed (Plastic-
sOne, Roanoke, VA, USA) under isofluorane anesthesia,
using a stereotactic alignment instrument (Kopf,
Tujunga, CA, USA) at the following coordinates relative
to bregma: -1.0 mm X, -0.5 mm Y and −2.25 mm Z. Ten
ng mouse IL-1β or 500 ng mouse tumor necrosis factor
(TNF, R&D, Minneapolis, MN, USA) injections were
given in 1 μL total volume. IL-1β and TNF were dis-
solved in artificial cerebrospinal fluid (aCSF, 150 mM
NaCl, 3 mM KCl, 1.4 mM CaCl2, 0.8 mM MgCl2, 1.0
mM NaPO4) with 0.1% endotoxin free BSA.
LPS injection
LPS (Sigma, St. Louis, MO, USA) was dissolved at 62.5
μg/mL in 0.9% saline/0.5% endotoxin free BSA, and
injected intraperitoneally at 4 μL/g body weight (250
μg/kg).
Locomotor activity measurement
Voluntary home cage LMA was measured using implan-
table telemetric transponders (MiniMitter, Bend, OR,
USA). Animals were anesthetized using 2% isoflurane, a
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small midline incision was made in the abdominal wall,
and transponders were implanted adjacent to the ab-
dominal aorta in the retroperitoneal space. Transponders
were implanted during the lateral ventricle cannulation
surgery. Mice were individually housed and allowed to
acclimate for at least five days before temperature and
net movement in x-, y- and z-axes was recorded in one
minute intervals (Vital View, MiniMitter).
Overnight feeding studies
Animals were transferred to clean cages and injected
with i.c.v. IL-1β (10 ng), i.c.v. TNF (500 ng) or i.p. LPS
(250 μg) 1 h prior to lights off. At 2, 6, 13, 24, 37 and 48
h after the onset of the dark cycle, food was weighed and
returned to the cage. Body weight was recorded at 13, 24
and 48 h.
Fast-refeed feeding studies
At lights out, food was removed from the cages and ani-
mals were fasted for 12 h. At the start of the light cycle,
animals were injected i.c.v with IL-1β (10 ng) and food
was returned to the cages 15 minutes later. Food intake
was measured at 1, 2, 5, 8, 12 and 24 h after the return
of food to the cages.
Immunohistochemistry
For histology experiments, mice were deeply anesthe-
tized using a ketamine cocktail and sacrificed by trans-
cardial perfusion fixation with 15 mL ice cold 0.01 M
PBS + heparin sodium (15,000 U/L) followed by 25 mL
4% paraformadehyde (PFA) in 0.01 M PBS. Brains were
post-fixed in 4% PFA overnight at 4°C and cryoprotected
in 20% sucrose for 24 h at 4°C before being stored at
−80°C until used for immunohistochemistry (IHC). Dual-
immunofluorescence histochemistry was performed as
described below. Free-floating sections were cut at 30
μm from perfused brains using a sliding microtome
(Leica SM2000R, Leica Microsystems, Bannockburn, IL,
USA). Hypothalamic sections were collected from the
division of the optic chiasm (bregma −1.0 mm) caudally
through the mammillary bodies (bregma −3.0 mm). The
sections were incubated for 1 h at room temperature in
blocking reagent (5% normal donkey serum in 0.01 M
PBS and 0.1% Triton X-100). After the initial blocking
step, the sections were incubated in mouse anti-NeuN
(1:1,000, Millipore, Billerica, MA, USA), rabbit anti-GFAP
(1:500, DAKO, Carpinteria, CA, USA), rabbit anti-IbaI
(1:500, DAKO), rat anti-CD31 (1:100, BD Pharmingen,
Sparks, MD, USA) in blocking reagent for 72 h at 4°C,
followed by incubation in donkey anti-rabbit Alexa 488
(1:500), donkey anti-mouse Alexa 488 or 647 (1:500),
goat anti-rat Alexa 488 or 633 (1:500, Invitrogen) for 2 h
at room temperature. Between each stage, the sections
were washed thoroughly with 0.01 M PBS. Incubating
the sections in the absence of primary antisera was used
to ensure specificity of the secondary antibodies. Sec-
tions were mounted onto gelatin-coated slides, cover-
slipped using Vectashield mounting media (Vector
Laboratories, Burlingame, CA, USA), and viewed on a
Nikon A1 inverted laser-scanning confocal microscope
(Nikon Instruments, Melville, NY, USA). Sections from
Nestin-cre x GNZ animals were cut at 75 μm on a vibra-
tome (Leica Microsystems, Buffalo Grove, IL, USA).
Sections were incubated for 30 minutes in 98°C pH 6 so-
dium citrate buffer, then blocked as above. Sections were
then incubated overnight at 4°C in 1:500 chicken anti-
GFP antibody (Aves, Tigard, OR, USA). Sections were
then washed as above, and incubated for 1 h in goat
anti-chicken Alexa 568 and 647. Images were obtained
as above, and both red and far red channels superim-
posed to generate higher anti-GFP signal.
Neuronal cultures
Embryonic Day 14.5 (E14.5) timed pregnant female Nes-
tin-cre/tdTomato mice were sacrificed by cervical dis-
location and embryos were collected in cold complete
HBSS. Heads were removed and cortices and hypothal-
ami dissected and collected in cold complete HBSS. Tails
were collected to confirm genotyping. Cortical and hypo-
thalamic neurons were dissociated and were cultured for
five days on Poly-D-Lysine-Laminin-coated glass cover-
slips in serum-free Gibco Neurobasal Medium contain-
ing Invitrogen penicillin-streptomycin and Invitrogen
B-27 Supplement. Neurons were fixed in 4% paraformalde-
hyde in 1X PBS for 20 minutes at room temperature,
then blocked and immunostained in a 1% BSA, 0.1%
cold fish skin gelatin, 0.5% Triton-X 100, 10 mM TBS
solution (blocking buffer). Neurons were immunostained
overnight for MAP2 (1:1,000, Aves), Tau (1:10,000,
Chemicon, Billerica, MA), NeuN (1:1,000, Chemicon)
and βIII Tubulin (1:1,000, Chemicon) to confirm polar-
ity and neuronal identity, respectively. Primary anti-
bodies were applied overnight at 4°C and were washed
off the next day 3x with 1XPBS. Hoechst and Alexa-
Fluor secondary antibodies were used at 1:1,000 for one
hour at room temperature in blocking buffer. Cover-
slips were mounted on slides and imaged on a Nikon
A1 inverted laser-scanning confocal microscope. Neu-
rons were scored for the presence of TdTomato using
ImageJ software is open source free software from the
National Institutes of Health. It is available at http://
rsbweb.nih.gov/ij/download.html to determine efficiency
of recombination.
Western blot
Muscles were homogenized in cell lysis buffer (Cell Sig-
naling, Danvers, MA, USA): 20 mM Tris pH 7.5, 150
mM NaCl, 1 mM EDTA, 1 mM EGTA 1% Triton X, 2.5
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mM sodium pyrophosphate, 1 mM beta-glyceropho-
sphate, 1 mM sodium orthovanadate, 1 ug/mL leupeptin,
and supplemented with Complete protease inhibitors
(Roche, Indianapolis, IN, USA), 1 mM PMSF (Sigma),
and 5 μL/mL phosphatase inibitor cocktail II (Sigma).
Samples were homogenized for 30 s using a Polytron
homogenizer (Kinematica, Bohemia, NY, USA), then
were sonicated 2 x 10s. Samples were then centrifuged at
13,000 RPM for 10 minutes at 4°C. For Western blots,
100 ug of total protein per lane was run on Criterion 4
to 15% gradient polyacrylamide gels (Biorad, Hercules,
CA, USA), and transferred to Immobilon PVDF mem-
branes (Millipore. Proteins were detected using a Lumi-
Imager (Roche) and SuperSignal West Pico Chemilu-
minescent Substrate (Thermo, Rockford, IL, USA). The
following antibodies were used: rabbit anti-MyD88 (Cell
Signaling) and an anti-rabbit HRP conjugate (Promega,
Madison, WI, USA).
Results
MyD88 is requisite for sickness behavior in response to
centrally administered cytokine MyD88 is essential for
conveying the anorectic signal in response to peripheral
LPS or IL-1β treatment. It has been proposed that fast
IL-1β signaling in anterior hypothalamic neurons occurs
in a phosphatidylinositol 3-kinase (PI3K)-dependent,
MyD88-independent mechanism [17]. To examine wheth-
er MyD88 is requisite for the behavioral response to cyto-
kines administered directly into the brain, we investigated
the response of MyD88KO mice to i.c.v injection of
IL-1β. Injections of IL-1β (10 ng) or vehicle (veh) were
performed one hour before lights off at Zeitgeber
time (ZT) 11 to 12. Although WT mice showed a sig-
nificant suppression of dark-phase food intake in re-
sponse to IL-1β (Figure 1a), feeding in MyD88KO
mice was unperturbed. WT mice lost body weight in
response to IL-1β treatment, whereas MyD88 mice
were undistinguishable from veh-treated controls
(Figure 1b). WT mice treated with IL-1β showed sig-
nificant suppression of home cage LMA for the first 8
h of the dark cycle, whereas MyD88KO mice treated
with IL-1β exhibited normal LMA (Figure 1c, d). These
data demonstrate that MyD88 is required for sickness
behavior in response to IL-1β applied into the lateral
ventricle.
To validate that MyD88KO mice are capable of dis-
playing sickness behavior in response to a MyD88-
independent inflammatory stimulus, we performed i.c.v.
injections of the MyD88 independent cytokine TNF (500
ng) in MyD88KO mice. As TNF is a far less potent in-
ducer of sickness behavior than IL-1β, and the purpose
of this experiment was not to model physiologic inflam-
mation, but to rule out developmental limitations, a rela-
tively high dose of the cytokine was used. Anorexia,
weight loss and decreased LMA were all present in
MyD88KO mice treated with TNF during the first six
hours after treatment (Figure 1e-h). During the sec-
ond half of the dark phase, TNF-treated MyD88KO
mice consumed more food than veh-treated controls
such that no differences in cumulative food intake
were apparent 13 h after treatment. Thus, MyD88KO
mice display normal sickness behavior at early time
points in response to an inflammatory challenge that
does not require MyD88. The limited duration of
this effect demonstrates that MyD88 is important for
the propagation of sickness behavior beyond the
acute period irrespective of the inciting inflammatory
stimulus.
Nes-cre mice exhibit cre-mediated recombination in
neurons
To explore the identity of the cell population in which
MyD88 is requisite for the behavioral response to inflam-
mation, we generated mice lacking MyD88 exclusively in
the central nervous system (MyD88ΔCNS). Mice expres-
sing cre recombinase under the control of the rat nestin
promoter were crossed with mice harboring an allele of
MyD88 where exon 3 of the gene is flanked by LoxP sites
to generate CNS specific deletion of MyD88. These mice
display no overt phenotype until challenged with a high
fat diet, despite appropriate recombination [18]. While
the Nestin-cre mouse has been utilized extensively, reports
vary as to the precise identity of cells in the CNS exhibit-
ing recombinase activity. To clarify this issue, we crossed
the Nestin-cre mouse to an inducible reporter in which
the tdTomato fluorescent protein is expressed in cells that
have expressed cre recombinase at any point during their
development. Upon dissection following perfusion fix-
ation, the brains were grossly red compared to WT
(Figure 2a). Although tdTomato fluorescence is widely
visualized throughout the coronal brain sections, this
staining is specific, as evidenced by sharply demarcated
nuclear clearing. In the hypothalamus, high power
confocal images demonstrate nuclear clearing of the
cytosolic tdTomato and staining of a subnuclear com-
partment by the neuronal marker NeuN, indicative of
cre-mediated recombination in neurons (Figure 2b).
Thus, the tdTomato protein appears to be only cytosolic
in the vast majority of neurons, which is consistent with
multiple reports examining the neuronal expression of
genetically-encoded fluorescent proteins that lack a nu-
clear localization signal [19].
To further confirm recombination in neurons, we isolated
and cultured hypothalamic and cortical neurons from Nes-
tin-cre/tdTomato reporter mice and costained them with
antibodies against neuronal markers NeuN, Map2, Tau and
β3 Tubulin. We did not observe any cultured cells with
neuronal phenotype that did not express tdTomato
Braun et al. Journal of Neuroinflammation 2012, 9:229 Page 4 of 12
http://www.jneuroinflammation.com/content/9/1/229
fluorescence (Figures 2c, d). As a control, neurons from
tdTomato reporter mice lacking cre-7expression were har-
vested, stained and visualized using identical microscope
settings. We observed no red fluorescence in any control
mice, verifying the specificity of the Nestin-cre recombin-
ation (Figure 2e). Because tdTomato is only expressed in
the cytoplasm, we wanted to verify that the diffuse tdTo-
mato fluorescence accurately represented pan-neuronal re-
combination. To do so we crossed the Nes-cre mouse with
the GNZ reporter mouse, in which nuclear-localized GFP is
conditionally expressed in cells expressing cre-recombinase.
We observed densely labeled nuclei in all brain regions, in-
cluding the hypothalamus, with absence of staining in the
cytoplasm, consistent with pan-neuronal recombination
(Figure 2f).
Nes-cre mice exhibit cre-mediated recombination in
astrocytes, but not microglia or cerebrovascular
endothelial cells
We also examined the expression of tdTomato in other
CNS cell types. GFAP positive astrocytes clearly express
tdTomato consistent with recombination in this cell type
(Figure 3a). However, cre recombinase activity is not
present in microglia (marked by Iba1) or endothelium
(marked by CD31), as demonstrated by a lack of tdTo-
mato expression in these cell types (Figure 3b, c). To
confirm the specificity of the tdTomato signal, hypothal-
amic sections from tdTomato negative and positive ani-
mals were examined using the same microscope settings,
with significantly increased signal evident in the red
channel for tdTomato positive animals (Figure 3d).
Figure 1 MyD88 is required for sickness behavior in response to central IL-1β injection. WT and MyD88KO mice received i.c.v. injections of
IL-1β (10 ng) or TNF (500 ng) 1 h before the onset of the dark cycle (n = 5 to 6/group). (a, e) Cumulative food intake. (b, f) Overnight change in
body weight. (c, g) Hourly locomotor activity. (d, h) Cumulative locomotor activity over 8 h post injection. All data are represented as mean ± s.e.
m. In some cases, error bars are too small to see. KO, MyD88KO; ZT, Zeitgeber Time. ***, P <0.001; **, P <0.01; *, P <0.05 as measured by two-way
ANOVA with Bonferroni post-test.
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Brain MyD88 expression is significantly reduced in
MyD88ΔCNS mice
To verify that MyD88 was deleted from the brains of
MyD88ΔCNS animals, we examined MyD88 protein ex-
pression from MyD88ΔCNS and MyD88lox control mice.
Western blot analysis demonstrates a marked reduction
in MyD88 protein expression in brains from MyD88ΔCNS
mice compared to control animals (Figure 4). A very
faint band can be seen in the MyD88ΔCNS mice, consist-
ent with residual expression in non-Nestin expressing
microglia and cerebrovascular endothelial cells.
Deletion of MyD88 from neurons and astrocytes does not
alter sickness behavior in response to IL-1β or LPS
We assessed the behavioral response of MyD88ΔCNS mice
to IL-1β administered prior to the onset of the dark cycle
(ZT 11–12). MyD88ΔCNS mice displayed normal suppres-
sion of overnight feeding and body weight in response to i.
c.v. IL-1β (Figure 5a, b). Spontaneous home cage activity
was suppressed equally in MyD88ΔCNS and MyD88lox mice
treated with i.c.v. IL-1β (Figure 5c, d). It is possible that the
neuronal response to i.c.v. IL-1β is transient, requiring in-
flammatory amplification by a population of cells not
expressing cre, such as microglia or endothelium, to sustain
the anorectic response. Were this the case, attenuation of
the behavioral response to i.c.v. IL-1β in the MyD88ΔCNS
mouse would only be observable at early time-points prior
to amplification of this signal into a polycytokine response,
which would circumvent the block in neuronal MyD88 sig-
naling. To evaluate this possibility, we repeated these
experiments in mice fasted for 12 h prior to i.c.v. IL-1β
treatment. Fasting increases the relative fraction of food in-
take occurring within the first two hours, enhancing the
sensitivity of the experiment to acute feeding differences.
Again, IL-1β was equally effective at reducing food intake in
both MyD88ΔCNS and MyD88lox mice at all time points
(Figure 6a-d). Collectively, these data demonstrate that
MyD88 expression in neurons and astrocytes is dispensable
for IL-1β-induced sickness behavior.
MyD88 is not required in neurons or astrocytes for LPS-
induced sickness behavior
LPS derives its anorectic effects through enhanced IL-1β
expression within the brain [7]. Although inflammatory
signaling pathways downstream of TLR4 can be activated
independent of MyD88, MyD88KO mice fail to mount a
cytokine response to treatment with the TLR4 ligand,
LPS [20]. Furthermore, IL-1β immunoreactivity has
been observed in both astrocytes and neurons [21,22].
To evaluate whether MyD88 is necessary in these cell
types for the behavioral response to LPS, we treated
MyD88ΔCNS mice with peripheral LPS injections. One
hour prior to the onset of the dark cycle, MyD88ΔCNS
mice were injected i.p. with LPS (250 μg/kg) or veh.
Overnight and 2 h food intake was reduced in both
MyD88Lox and MyD88ΔCNS mice (Figure 7a, b). LPS
treatment resulted in a significant loss of body weight,
without evident differences between genotypes (Figure 7c).
Home cage activity was suppressed by LPS admin-
istration for the entire duration of the dark cycle
(Figure 7d, e). Therefore, expression of MyD88 in neu-
rons or astrocytes is not required for LPS-induced sick-
ness behavior.
Discussion
Sickness behavior is an integral component of the adap-
tive metabolic response to infection. In chronically ill
patients this response becomes maladaptive, significantly
worsening quality of life and potentially contributing to
mortality. Despite numerous mechanistic inroads into
the pathogenesis of sickness behavior, the precise cell
type upon which IL-1β acts to produce sickness behavior
has remained elusive. In this work, we demonstrate a re-
quirement for MyD88 in transducing IL-1β within the
brain into sickness behavior. Although MyD88 expres-
sion in neurons has been suggested to play a critical role
in the behavioral response to inflammation, we find that
IL-1β induced anorexia and lethargy is not contingent
upon MyD88-expression in both neurons and astrocytes.
The receptor for IL-1β is expressed in multiple loca-
tions within the CNS, many of which are known to regu-
late food intake. In particular, IL-1R1) is expressed in the
arcuate nucleus of the hypothalamus (ARC) on anorectic
proopiomelanocortin (POMC) and orexigenic Agouti
Related Peptide (AgRP) neurons. IL-1β increases the fir-
ing of POMC neurons, and increases the release of
alpha-melanocyte stimulating hormone (α-MSH), the
natural ligand of the type-4 melanocortin receptor
(See figure on previous page.)
Figure 2 Nestin-cre drives recombination in neurons. (a) Gross images of tdTomato x Nes cre mouse brains showing diffuse expression of the
tdTomato protein throughout the central nervous system. Brains from Nes-cre/tdTomato reporter mice were immunostained with antibodies
against NeuN labeling neuronal nuclei. Images seen in (b) show high magnification of brains from Nes-cre/tdTomato reporter mice
immunostained with antibodies against NeuN to examine co-expression. High power photomicrographs showing cultured cortical neurons from
E14.5 Nes-cre/tdTomato mice immunostained with antibodies against neuron-specific proteins NeuN and β3 tubulin (c) or Tau and Map2 (d).
Cultured cortical neurons from E14.5 Nes-cre−/−/tdTomato negative control mice stained for Tau and Map2 using the same microscope settings as
in (c). Tissue sections from Nes-cre/GNZ mouse hypothalami demonstrating dense nuclear GFP expression (f). Representative images in (f) of the
ARC at −1.20 to −1.70 mm relative to bregma. Scale bars, (b) 10 μm, (c, d, e) 50 μm, (f) 100 μm-low power; 50 μm-high power.
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(MC4R), from hypothalamic explants [12]. IL-1β simul-
taneously decreases the release of AgRP, the endogenous
antagonist of the MC4R [13]. Consistent with this, mice
lacking the MC4R resist IL-1β induced anorexia, demon-
strating that alterations in melanocortin signaling under-
lie changes in feeding in response to IL-1β [23].
Despite clear recombination in the ARC in the tdTo-
mato reporter mouse, MyD88ΔCNS mice respond nor-
mally to IL-1β. There are several possible explanations to
resolve these apparently conflicting results. Cre mediated
recombination of the MyD88 allele may be incomplete,
with a sufficient number of neurons remaining
Figure 3 Nestin-cre drives recombination in astrocytes but not endothelium or microglia. Brains from Nes-cre tdTomato reporter mice
were immunostained with antibodies against (a) GFAP marking astrocytes, (b) Iba1 labeling microglia or (c) CD31 labeling endothelium. (d)
tdTomato negative and tdTomato positive sections doubled labeled for CD31. Scale bar represents 10 μm for a, b, c and 100 μm for d.
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responsive to IL-1β in the MyD88ΔCNS mouse to engen-
der a normal anorectic response. If the results of our tis-
sue and cell culture IHC are representative, less than 1%
of neurons are sufficient to mediate these behaviors. Al-
ternatively, it is possible that IL-1β produces anorexia in
an IL-1RI mediated, MyD88-independent manner. There
is some precedence for this, as it has been proposed that
IL-1β signals via a PI3K dependent mechanism in neu-
rons, similar to the mechanism by which leptin mediates
electrophysiologic changes in neurons [17]. A third pos-
sibility is that cytokine signaling has an obligate amplifi-
cation step in a cell type that does not undergo
recombination in the MyD88ΔCNS mouse, leading to the
paracrine release of a second messenger that then con-
veys the anorectic signal to neurons.
The identity of this second messenger remains in ques-
tion. Some propose that prostaglandins convey the in-
flammatory signal to neurons [15,16,24]. Whereas this is
clearly the case for fever [25], cyclooxygenase inhibition
fails to alter the changes in volitional activity observed
after i.p. LPS injection [10], and decreases, but does not
block, the anorectic response to peripheral and central
inflammatory challenges [11,26,27]. Therefore, while
prostaglandins mediate some of the behavioral response
to systemic inflammation, other second messengers must
also relay inflammatory signals to the neurons regulating
behavior.
IL-1β itself may be the ultimate mediator of
inflammation-induced anorexia. Previous work by
Konsman et al. demonstrates that i.c.v. administration
of IL-1β to rats diffuses throughout the parenchyma,
eliciting neuronal activation [28]. These cellular
responses may be secondary to direct activation of the
IL-1RI on neurons by IL-1β that has diffused from
the ventricles. It is also possible that IL-1β, at the
doses given in the present study, does not reach suffi-
cient concentration after i.c.v. injection to engage the
IL-1RI on feeding center neurons, yet is amplified lo-
cally by a non-neuronal cell. There is some experi-
mental evidence to support this mechanism. First, i.c.v.
IL-1β exhibits preferential perivascular diffusion, suggest-
ing a role for perivascular or endothelial amplification in
its acute effects [28]. Second, IL-1β mRNA increases
specifically in the parenchyma of the ARC following i.c.v.
IL-1β or i.p. LPS administration [29]. When IL-1 receptor
Figure 4 MyD88 expression is reduced in brains from
MyD88ΔCNS mice. Western blots were performed on equal amounts
of proteins from homogenized brains from MyD88ΔCNS or MyD88Lox
control mice using antibodies against MyD88. Three replicate results
from one experiment are shown. Replicates were immunostained for
actin as a loading control.
Figure 5 MyD88 expression in the CNS is not required for IL-1β-induced sickness behavior. WT and MyD88ΔCNS mice received i.c.v.
injections of IL-1β (10 ng) 1 h before the onset of the dark cycle (n = 4 to 9/group). (a) Cumulative food intake. (b) Overnight change in BW. (c)
Hourly locomotor activity. (d) Cumulative locomotor activity over 8 h post injection. All data are represented as the mean ± s.e.m. In some cases
error bars are too small to see. Lox, MyD88Lox/lox; ΔCNS, MyD88ΔCNS; ZT, Zeitgeber Time. ***, P <0.001; **, P <0.01; *, P <0.05 as measured by two-
way ANOVA with Bonferroni post-test.
Braun et al. Journal of Neuroinflammation 2012, 9:229 Page 9 of 12
http://www.jneuroinflammation.com/content/9/1/229
antagonist (IL-1Ra) is administered at a high dose during
peripheral endotoxemia, anorexia is prevented, demon-
strating that endogenous brain IL-1 signaling is integral to
the anorectic response [7]. Endogenous IL-1 signaling also
plays a role in mediating protein catabolism, as i.c.v. infu-
sion of IL-1Ra attenuates the loss of muscle mass in
experimental sepsis models [30]. However, in order
for this mechanism to be consistent with the presented
Figure 6 MyD88 expression in the CNS is not required for IL-1β-induced suppression of refeeding. WT and MyD88ΔCNS mice were fasted
overnight for 12 h and then received i.c.v. injections of IL-1β (10 ng) 15 minutes prior to food being returned to the cages (n = 4 to 5/group). (a)
Cumulative food intake 0 to 5 h. (b) Cumulative food intake at 2 h. (c) Cumulative food intake 0 to 36 h. (d) Cumulative food intake at 24 h. All
data are represented as the mean ± s.e.m. ΔCNS, MyD88ΔCNS. ** ; P <0.01, * ; P <0.05 as measured by two-way ANOVA with Bonferroni post-test.
Figure 7 MyD88 expression in the CNS is not required for LPS-induced sickness behavior. WT and MyD88ΔCNS mice received i.p. injections
of LPS (250 μg/kg) 1 h before the onset of the dark cycle (n = 4 to 9/group). (a) Cumulative food intake. (b) Cumulative food intake at 2 h post
injection. (c) Change in body weight after LPS injection. (d) Hourly locomotor activity. (e) Cumulative locomotor activity during the entire night
cycle. All data are represented as the mean ± s.e.m. In some cases error bars are too small to see. Lox, MyD88Lox/lox; ΔCNS, MyD88ΔCNS; ZT,
Zeitgeber Time. *** , P <0.001 as measured by two-way ANOVA with Bonferroni post-test.
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data, the induction of hypothalamic IL-1β would have to
be dependent on MyD88, yet its ultimate action on neu-
rons is independent from MyD88. As evidence exists from
other cell types that cytokine production is dependent on
MyD88 [31], and IL-1β signaling on neurons is MyD88 in-
dependent [17], this remains a plausible explanation for
the data presented here.
Logical targets for IL-1β signaling in the context of
these findings are cerebrovascular endothelial cells.
Endothelial knockdown of the IL-1RI blocks the suppres-
sion of home cage LMA after i.c.v. IL-1β injection and
prevents the activation of neurons in the paraventricular
nucleus (PVN) of the hypothalamus, which is associated
with hypothalamic-pituitary-adrenal, sympathetic nervous
system and anorectic responses to inflammation [15]. Fur-
thermore, brain endothelial specific knockout of trans-
forming growth factor β-activated kinase attenuates the
depression in LMA seen after IL-1β administration [16].
Perivascular macrophages have also been implicated as
key intermediaries in the central response to inflamma-
tion. Selective depletion of perivascular macrophages
decreases the activation PVN neurons in response to per-
ipheral IL-1β but does not alter the depression of LMA
[14]. Neither endothelium nor microglia show cre-
mediated recombination in the Nestin-cre mice. There-
fore, endothelium and perivascular macrophages likely
represent a component of the cell population in which
MyD88 is required for sickness behavior.
Conclusions
In summary, our results demonstrate that MyD88 is
not required in neurons or astrocytes to induce the
behavioral response to i.c.v. IL-1β. This suggests that
a non-nestin expressing cell population in the CNS
responds to IL-1β and transduces the signal to neu-
rons controlling feeding and activity. We posit that
cerebrovascular cells or perivascular macrophages/
microglia are the most likely targets for IL-1β signal-
ing in the brain, implying that systemic therapy
addressing anorexia and fatigue need not penetrate
the blood brain barrier.
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